戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nase inhibitors as a therapeutic strategy in Lowe syndrome.
2 ns result in a myriad of phenotypes found in Lowe syndrome.
3  ciliary dysfunction in the manifestation of Lowe syndrome.
4 raffic leads to the neurological symptoms of Lowe syndrome.
5 ous system and ocular defects in the case of Lowe syndrome.
6 cal abnormalities that are characteristic of Lowe syndrome.
7 toskeleton in fibroblasts from patients with Lowe syndrome.
8 in this activity result in the human disease Lowe syndrome.
9 ile 85% of the values are from patients with Lowe syndrome.
10 l polyphosphate 5-phosphatase, is mutated in Lowe syndrome.
11 culocerebral renal syndrome of Lowe (OCRL or Lowe syndrome), a severe X-linked congenital disorder ch
12 PIP2 in human fibroblasts from patients with Lowe syndrome, a genetic disorder that affects phosphoin
13                                              Lowe syndrome, a multisystem disease characterized by re
14 al enzymes in the plasma of 15 patients with Lowe syndrome and 15 age-matched male controls.
15 om kidney proximal tubules of a patient with Lowe syndrome and a normal individual were used to study
16                                              Lowe syndrome and Dent disease are two conditions that r
17  and are consistent with a scenario in which Lowe syndrome and Dent disease result from perturbations
18    OCRL, whose mutations are responsible for Lowe syndrome and Dent disease, and INPP5B are two simil
19 ons in the inositol 5-phosphatase OCRL cause Lowe syndrome and Dent's disease.
20 n of the inositol 5-phosphatase OCRL1 causes Lowe syndrome and Dent-2 disease.
21 L1 leads to the phenotypic manifestations of Lowe syndrome are currently unclear, in part, owing to t
22                                              Lowe syndrome-associated mutations in OCRL result in sho
23                          The pathogenesis of Lowe syndrome due to deficiency of a phosphatidylinosito
24 or disorders resulting from mutations in the Lowe syndrome gene OCRL1 need to be revised.
25                                          The Lowe syndrome gene, OCRL1, encodes a phosphatidylinosito
26                                              Lowe syndrome is a rare X-linked congenital disease that
27                                              Lowe syndrome is a rare X-linked disorder characterized
28                                              Lowe syndrome is an X-linked disorder that has a complex
29                                              Lowe syndrome (LS) is a devastating, X-linked genetic di
30                                          The Lowe syndrome (LS) is a life-threatening, developmental
31                 Unlike patients with typical Lowe syndrome, none of these patients had metabolic acid
32 he gene that when mutated is responsible for Lowe syndrome, or oculocerebrorenal syndrome (OCRL), is
33               Here we show that OCRL loss in Lowe syndrome patient fibroblasts impacts clathrin-media
34                           The cells from the Lowe syndrome patient lack OCRL protein.
35 nclusion, we report novel OCRL1 mutations in Lowe syndrome patients and the corresponding histopathol
36 ntified two novel mutations in two unrelated Lowe syndrome patients with congenital glaucoma.
37 logical defects similar to those reported in Lowe syndrome patients, namely increased susceptibility
38 ) 5-phosphatase deficiency might produce the Lowe syndrome phenotype.
39                                              Lowe syndrome results from mutations in the OCRL1 gene,
40 s more-extensive phenotypic heterogeneity in Lowe syndrome than was previously appreciated.
41 ysosomal enzyme trafficking in patients with Lowe syndrome that leads to increased extracellular lyso
42      Here, we describe a zebrafish model for Lowe syndrome using stable and transient suppression of
43 lyphosphate 5-phosphatase that is mutated in Lowe syndrome, was investigated by fluorescence microsco
44                                              Lowe syndrome, which is characterized by defects in the
45 sitol 5-phosphatase OCRL are responsible for Lowe syndrome, whose manifestations include mental retar

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。